title: miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.
abstract: The activities of RNA-binding proteins are perturbed in several pathological conditions, including cancer. These proteins include tristetraprolin (TTP, ZFP36) and HuR (ELAVL1), which respectively promote the decay or stability of adenylate-uridylate-rich (AU-rich) mRNAs. Here, we demonstrated that increased stabilization and subsequent over-expression of HuR mRNA were coupled to TTP deficiency. These findings were observed in breast cancer cell lines with an invasive phenotype and were further confirmed in ZFP36-knockout mouse fibroblasts. We show that TTP-HuR imbalance correlated with increased expression of AU-rich element (ARE) mRNAs that code for cancer invasion genes. The microRNA miR-29a was abundant in invasive breast cancer cells when compared to non-tumourigenic cell types. When normal breast cells were treated with miR-29a, HuR mRNA and protein expression were up-regulated. MiR-29a recognized a seed target in the TTP 3' UTR and a cell-permeable miR-29a inhibitor increased TTP activity towards HuR 3' UTR. This led to HuR mRNA destabilization and restoration of the aberrant TTP-HuR axis. Subsequently, the cancer invasion factors uPA, MMP-1 and MMP-13, and cell invasiveness, were decreased. The TTP:HuR mRNA ratios were also perturbed in samples from invasive breast cancer patients when compared with normal tissues, and were associated with invasion gene expression. This study demonstrates that an aberrant ARE-mediated pathway in invasive cancer can be normalized by targeting the aberrant and functionally coupled TTP-HuR axis, indicating a potential therapeutic approach.
authors: Molecular Biomedicine Programme, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
authors: Wijdan
authors: W
authors: Al-Ahmadi
authors: Maha
authors: M
authors: Al-Ghamdi
authors: Norah
authors: N
authors: Al-Souhibani
authors: Khalid S A
authors: KS
authors: Khabar
mesh_terms: D000225:Adenine / Q000378:metabolism; D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology*; D051959:ELAV Proteins / Q000235:genetics*; D005260:Female; D005347:Fibroblasts / Q000166:cytology; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D057809:HEK293 Cells; D006801:Humans; D061986:MCF-7 Cells; D051379:Mice; D018345:Mice, Knockout; D035683:MicroRNAs / Q000235:genetics*; D009361:Neoplasm Invasiveness; D010641:Phenotype; D020871:RNA Stability / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D051816:Tristetraprolin / Q000235:genetics; D014498:Uracil / Q000378:metabolism
chemical_list: D051959:ELAV Proteins; C532045:MIRN29a microRNA, human; D035683:MicroRNAs; D012333:RNA, Messenger; D051816:Tristetraprolin; C497552:ZFP36 protein, human; D014498:Uracil; D000225:Adenine
references: Cancer Res. 2008 Feb 1;68(3):674-82
references: 18245466
references: J Clin Invest. 2001 Dec;108(11):1657-65
references: 11733561
references: Clin Cancer Res. 2004 Aug 15;10(16):5580-6
references: 15328200
references: J Biol Chem. 2012 Aug 17;287(34):28770-8
references: 22700982
references: J Pathol. 2011 Aug;224(4):529-39
references: 21480233
references: Nat Protoc. 2006;1(1):302-7
references: 17406249
references: Am J Physiol Cell Physiol. 2011 Sep;301(3):C609-18
references: 21593445
references: EMBO Rep. 2009 Apr;10(4):400-5
references: 19247375
references: Biochem Biophys Res Commun. 2010 Jan 1;391(1):963-8
references: 19962963
references: Ageing Res Rev. 2012 Sep;11(4):473-84
references: 22387927
references: Mol Ther. 2012 May;20(5):954-9
references: 22434136
references: Eur J Cancer. 2009 Nov;45(17):3104-18
references: 19818597
references: Cancer Res. 2004 Jan 1;64(1):189-95
references: 14729623
references: Front Biosci (Landmark Ed). 2012 Jan 01;17:1846-60
references: 22201840
references: Cancer Res. 2009 Jun 15;69(12):5168-76
references: 19491267
references: Int J Cancer. 2010 Apr 15;126(8):1817-1827
references: 19697322
references: Artif DNA PNA XNA. 2011 Jul-Dec;2(3):90-9
references: 22567192
references: BMC Mol Biol. 2009 Mar 08;10:20
references: 19267938
references: Breast Cancer Res Treat. 2004 Feb;83(3):249-89
references: 14758095
references: Biol Cell. 2004 Sep;96(7):479-98
references: 15380615
references: Clin Cancer Res. 2005 Oct 15;11(20):7362-8
references: 16243808
references: Mol Cell Biol. 2006 Dec;26(24):9196-208
references: 17030620
references: RNA. 2010 Jun;16(6):1245-55
references: 20418359
references: Cell Mol Life Sci. 2010 Sep;67(17):2937-55
references: 20495997
references: Aging (Albany NY). 2009 Sep 10;1(9):803-17
references: 20157568
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D137-40
references: 17984078
references: Int J Oncol. 2008 Feb;32(2):341-7
references: 18202756
references: PLoS One. 2009 Jul 03;4(7):e6146
references: 19582160
references: Oncogene. 2009 Apr 16;28(15):1782-91
references: 19252527
references: Front Biosci (Landmark Ed). 2012 Jan 01;17:189-205
references: 22201738
references: Nucleic Acids Res. 2012 Dec;40(22):11531-44
references: 23066106
references: Oncogene. 2003 Oct 16;22(46):7146-54
references: 14562043
references: Nucleic Acids Res. 2012 Sep;40(16):7739-52
references: 22718976
references: Gastroenterology. 2009 May;136(5):1669-79
references: 19208339
references: Oncogene. 2010 Jul 22;29(29):4205-15
references: 20498646
references: Nucleic Acids Res. 2009 Jun;37(11):3612-24
references: 19359363
references: Nat Rev Genet. 2009 Oct;10(10):704-14
references: 19763153
references: Hepatogastroenterology. 2011 May-Jun;58(107-108):790-5
references: 21830391
references: Blood. 2010 Apr 1;115(13):2630-9
references: 20086245
references: Med Oncol. 2011 Dec;28 Suppl 1:S577-85
references: 21046284
references: Cancer. 2011 Jun 15;117(12):2677-89
references: 21656745
references: Front Biosci (Landmark Ed). 2012 Jan 01;17:174-88
references: 22201737
references: PLoS One. 2012;7(3):e33194
references: 22413002
references: Mod Pathol. 2006 Sep;19(9):1261-9
references: 16799479
references: J Leukoc Biol. 1994 Apr;55(4):552-6
references: 8145027
references: Cancer Res. 2005 Mar 15;65(6):2157-61
references: 15781626
references: J Neurooncol. 2012 Feb;106(3):531-42
references: 21935689